This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CardioNet Shares Rise On Leerink Analyst Upgrade

NEW YORK (AP) ¿ Shares of CardioNet Inc. gained ground Wednesday after a Leerink Swann Research analyst upgraded the stock, citing an "encouraging" outlook for the wireless heart-monitoring device maker.

Leerink analyst Rick Wise upgraded the stock to "outperform" from "market perform" while touting the company's potential for volume growth in the heart-monitoring device market, along with a restructuring move.

The stock rose 20 cents, or 3.3 percent, to $6.20 in afternoon trading. Shares have traded between $4.22 and $29.50 over the last 52 weeks.

"Now with a clear and detailed restructuring plan in place and still-strong volume growth ahead, we are more inclined to think that CardioNet is on track to deliver an improving outlook with potential for upside in 2010 and beyond," Wise said in a note to investors.

In November, the Conshohocken, Pa.-based company reported a third-quarter loss partly on higher marketing spending following a cut in Medicare reimbursement rates. Specifically, reimbursement rates were cut on mobile heart technology, which includes CardioNet devices.

The company now expects up to 40 percent volume growth in 2010 for its mobile cardiac outpatient telemetry device. CardioNet has also hired an investment bank to assess strategic alternatives, Wise said. Salesforce improvements and new uses for devices such as SomNet for the detection of obstructive sleep apnea have helped year-to-date volume growth, he added.

While Wise still expects reimbursement rate cuts over the next two years, he said the company has been working with the government to secure national pricing for its cardiac outpatient telemetry device.

Other positive developments for the company include a reorganization of the reimbursement services department, a new automated billing system, and outsourcing of the company's oldest receivables to a collections firm, Wise said.

He set a new stock value range of $8 to $10, up from $7.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
BEAT $8.04 -0.50%
AAPL $125.80 -2.25%
FB $77.56 -1.59%
GOOG $530.80 -1.85%
TSLA $232.95 1.06%

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs